Albany, NY -- (SBWire) -- 09/09/2017 --Smart pills have outperformed the conventional GI monitoring endoscopy with more convenient technology, which is becoming a standard non-invasive diagnosis technique for motility disorders. The emergence of these healthcare-cum-technology devices has addressed the soaring need for better imaging, diagnosis and monitoring of patient health. Moreover, it helps physicians in real-time patient monitoring. This is the essence of Persistence Market Researchs new publication titled Ingestible Smart Pills Market: Global Industry Analysis and Forecast, 20162024. While targeting geographies, the analysts have observed that currently, North America, Europe and Asia Pacific regions are target markets for major players in the global ingestible smart pills market.
On the other hand, while researching the segments, the analysts have found that the imaging application segment dominated the global ingestible smart pills market in terms of revenue in 2016. The analysts have differentiated key player strategies and have understood that the global ingestible smart pills market is characterized by the presence of both small and large-scale players. Key players are focusing on collaborations between companies and research institutes, partnerships and licensing agreements among companies and increasing research and development investment in smart pills.
Click to get sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1293581
In July 2016, Milacron Holdings launched eSTORE representing Milacron and Ferromatik branded Milacron extrusion machines, Mold-Masters hot runners and control systems fulfilling customers orders in North America and Europe. In January 2014, Baker Perkins re-organized its sales and service functions for its extrusion business to ensure customers benefit from a single point of contact for a wide range of services. In March 2013, Thermo Fisher Scientific Inc., launched the Thermo Scientific Pharma 11, a new version of parallel co-rating twin-screw extruder designed specifically for pharmaceutical research.
Browse more details at: http://www.researchmoz.us/global-market-study-on-ingestible-smart-pills-smart-pills-segment-by-component-likely-to-retain-its-dominance-through-2024-report.html
Porters analysis makes this report exclusive
- The degree of competition is high in the ingestible smart pills market
- Despite its nascent stage, the ingestible smart pills market displays intense competitive rivalry among top players
- Competition among these players is high due to competitive edge such as superior quality, low price and advanced features of these devices
- Although the major players dominate the market, there are a number of small players who have their components in the late stage of clinical trials and can pose a high competition during the forecasted period
- The ingestible smart pills market is dominated by a few leading manufacturers. Therefore the buyers have limited alternatives to choose from, which decreases their bargaining power
- Technological advances in the healthcare industry compel device and software developers to manufacture and commercialize new and sophisticated component-based devices, which increases the threat of new entrants
The global ingestible smart pills market report begins with an executive summary giving the market overview and the market taxonomy or segments covered in the report. It is followed by an overview of market dynamics of the global ingestible smart pills market, which includes Persistence Market Researchs analysis of key trends, drivers, restraints, and opportunities that are influencing the growth of the global ingestible smart pills market. It also includes an insight into component pricing for ingestible smart pills such as smart pills and workstation. Impact analysis of key growth drivers and restraints based on the weighted average model has been included in the global ingestible smart pills market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the market. In the final section of the report on the global ingestible smart pills market, a competitive landscape is included to provide report audiences with a dashboard view based on categories of providers in the global ingestible smart pills market.
Company Profiles
- BodyCap-Medical
- Philips Respironics
- Given Imaging Ltd.
- Olympus Corporation
- Proteus Digital Health, Inc.
- CapsoVision, Inc.
- Chongqing Jinshan Science and Component (Group) Co., Ltd.
- Medimetrics
- IntroMedic Co., Ltd.
- Check-Cap Ltd.
- Others
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Global Ingestible Smart Pills Market 2016-2024 : Smart Pills Segment by Component Likely to Retain Its Dominance Through 2024